Change in SEQENS’ shareholding structure
SEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read moreThis achievement reflects SEQENS strong commitment to reduce its environmental and carbon footprint in line with the Group ESG Program. SEQENS, an integrated…
Read moreFrom March 21 to 24, 2022, a delegation representing all of the group’s pharmaceutical activities took part in the DCAT event in New York.
Read moreInvestment Signals Major Commitment to U.S. Market and Builds on Merger with Contract Development and Manufacturing Organization Wavelength Pharmaceuticals. investment in Devens SEQENS,…
Read moreFor the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Virginie Tarlet Roussillon Lab manager. What is…
Read moreFor the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Aïna Queiroz, Head of innovation and scientific…
Read moreFor the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Yael Gofni analytical…
Read moreSeqens Solvents & Phenol Specialties (SPS) is proud to confirm that its isopropanol (IPA) plant capacity expansion, originally announced in Q2 2020 and…
Read moreSEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read moreAs announced on the 26th of August 2021, Eurazeo has finalized on Decembre 16th the sale of its stake in SEQENS to funds advised…
Read moreRoLA-FLEX is an industry-focused project that provides innovative solutions to the challenge associated with th performance and lifetime of Organic…
Read more